XML 92 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK-BASED COMPENSATION
3 Months Ended
Jun. 30, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
STOCK-BASED COMPENSATION

The Company recognizes the grant-date fair value of stock-based compensation as compensation expense using the straight-line attribution approach over the service period for which the stock-based compensation is expected to vest. The following table summarizes the amount of stock-based compensation included in the condensed consolidated statements of operations:
 
 
Three Months Ended
 
 
June 30,
(in thousands)
 
2013
 
2012
Cost of revenues
 
$
535

 
$
596

 
 


 


Research, development and engineering
 
1,368

 
1,124

Selling, general and administrative
 
3,085

 
2,900

Stock-based compensation included in operating expenses
 
4,453

 
4,024

Total stock-based compensation
 
4,988

 
4,620

Income tax benefit
 
(1,437
)
 
(1,382
)
Total stock-based compensation, net of tax
 
$
3,551

 
$
3,238



Stock Options

The following is a summary of the Company’s stock option activity during the three months ended June 30, 2013:
 
Options Outstanding
 
Number of
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual Life
 
Aggregate
Intrinsic
Value
 
(in thousands)
 
 
 
(in years)
 
(in thousands)
Outstanding at March 31, 2013
2,415

 
$
27.96

 
 
 
 
Options granted
151

 
$
45.68

 
 
 
 
Options exercised
(549
)
 
$
23.97

 
 
 
 
Options forfeited or expired
(8
)
 
$
31.63

 
 
 
 
Outstanding at June 30, 2013
2,009

 
$
30.36

 
4.2
 
$
27,517

Vested and expected to vest at June 30, 2013
1,960

 
$
30.17

 
4.2
 
$
27,178

Exercisable at June 30, 2013
1,298

 
$
27.09

 
3.3
 
$
21,844



The total intrinsic value of options exercised during the three months ended June 30, 2013 and 2012 was $12.2 million and $0.8 million, respectively.  Intrinsic value is defined as the amount by which the fair value of the underlying stock exceeds the exercise price at the time of option exercise. The total cash received as a result of stock option exercises during the three months ended June 30, 2013 was $13.2 million, net of taxes.

As of June 30, 2013, total unrecognized compensation cost related to unvested stock options was $6.6 million, which is expected to be recognized over a weighted average period of 2.0 years.

Restricted Stock

Restricted stock consists of awards of restricted stock and restricted stock units ("RSUs"). The following is a summary of the Company’s restricted stock activity during the three months ended June 30, 2013:
 
Number of
Shares
 
Weighted Average Grant Date Fair Value
 
(in thousands)
 
 
Non-vested at March 31, 2013
1,025

 
$
33.34

Restricted stock granted
517

 
$
46.11

Restricted stock vested
(226
)
 
$
32.35

Restricted stock forfeited
(11
)
 
$
36.29

Non-vested at June 30, 2013
1,305

 
$
38.55



The weighted average grant-date fair value of awards of restricted stock is based on the quoted market price of the Company's common stock on the date of grant. The weighted average grant-date fair value of restricted stock granted during the three months ended June 30, 2013 and 2012 was $46.11 and $31.10, respectively. The total fair value of restricted stock that vested during the three months ended June 30, 2013 and 2012 was $7.3 million and $3.7 million, respectively.

As of June 30, 2013, total unrecognized compensation cost related to unvested restricted stock was $37.5 million, which is expected to be recognized over a weighted average period of 2.6 years.  

Valuation Assumptions

The Company estimates the fair value of stock options and Employee Stock Purchase Plan (“ESPP”) shares using a Black-Scholes option valuation model.  At the date of grant, the Company estimated the fair value of each stock option grant and purchase right granted under the ESPP using the following weighted average assumptions:

 
 
Three Months Ended
 
 
June 30,
Employee Stock Options
 
2013
 
2012
Expected volatility
 
34.0
%
 
41.7
%
Risk-free interest rate
 
0.6
%
 
0.6
%
Expected dividends
 
0.9
%
 
1.3
%
Expected life (in years)
 
4.2

 
4.3

Weighted-average grant date fair value
 
$
11.86

 
$
10.30



No purchase rights were granted under the ESPP during the three months ended June 30, 2013 and 2012.